Article
Novel synaptobrevin‐1 mutation causes fatal congenital myasthenic syndrome
16 Jan 2017
Abstract excerpt
OBJECTIVE: To identify the molecular basis and elucidate the pathogenesis of a fatal congenital myasthenic syndrome. METHODS: We performed clinical electrophysiology studies, exome and Sanger sequencing, and analyzed functional consequences of the identified mutation. RESULTS: Clinical electrophysiology studies of the patient revealed several-fold potentiation of the evoked muscle action potential by high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
